193 related articles for article (PubMed ID: 20180585)
21. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
22. Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
Ponnusamy S; Lattmann E; Lattmann P; Thiyagarajan T; Padinjarethalakal BN; Narayanan R
Oncol Rep; 2016 Apr; 35(4):2097-106. PubMed ID: 26820391
[TBL] [Abstract][Full Text] [Related]
23. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.
Liu F; Le W; Mei T; Wang T; Chen L; Lei Y; Cui S; Chen B; Cui Z; Shao C
Int J Nanomedicine; 2016; 11():2195-207. PubMed ID: 27274243
[TBL] [Abstract][Full Text] [Related]
25. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
26. Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles.
Yeh CS; Su CH; Ho WY; Huang CC; Chang JC; Chien YH; Hung ST; Liau MC; Ho HY
Biomaterials; 2013 Jul; 34(22):5677-88. PubMed ID: 23639532
[TBL] [Abstract][Full Text] [Related]
27. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
[TBL] [Abstract][Full Text] [Related]
28. Indocyanine green-containing nanostructure as near infrared dual-functional targeting probes for optical imaging and photothermal therapy.
Zheng X; Xing D; Zhou F; Wu B; Chen WR
Mol Pharm; 2011 Apr; 8(2):447-56. PubMed ID: 21197955
[TBL] [Abstract][Full Text] [Related]
29. Water-Responsive Hybrid Nanoparticles Codelivering ICG and DOX Effectively Treat Breast Cancer via Hyperthermia-aided DOX Functionality and Drug Penetration.
Liu X; Wang C; Ma H; Yu F; Hu F; Yuan H
Adv Healthc Mater; 2019 Apr; 8(8):e1801486. PubMed ID: 30856296
[TBL] [Abstract][Full Text] [Related]
30. Albumin Based Nanoparticles for Detection of Pancreatic Cancer Cells.
Karaca N; Ünlüer ÖB
Protein Pept Lett; 2019; 26(4):271-280. PubMed ID: 30659529
[TBL] [Abstract][Full Text] [Related]
31. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.
Heidari Z; Sariri R; Salouti M
J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991
[TBL] [Abstract][Full Text] [Related]
32. Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted photochemotherapy of breast cancer cells.
Lee YH; Chang DS
Sci Rep; 2017 Apr; 7():46688. PubMed ID: 28429764
[TBL] [Abstract][Full Text] [Related]
33. Facile assembly of upconversion nanoparticle-based micelles for active targeted dual-mode imaging in pancreatic cancer.
Han Y; An Y; Jia G; Wang X; He C; Ding Y; Tang Q
J Nanobiotechnology; 2018 Jan; 16(1):7. PubMed ID: 29378593
[TBL] [Abstract][Full Text] [Related]
34. CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.
Nock BA; Maina T; Béhé M; Nikolopoulou A; Gotthardt M; Schmitt JS; Behr TM; Mäcke HR
J Nucl Med; 2005 Oct; 46(10):1727-36. PubMed ID: 16204724
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer.
Zou J; Chen S; Li Y; Zeng L; Lian G; Li J; Chen S; Huang K; Chen Y
Nanoscale; 2020 Feb; 12(7):4473-4490. PubMed ID: 32031201
[TBL] [Abstract][Full Text] [Related]
36. Dual-Labeled Near-Infrared/(99m)Tc Imaging Probes Using PAMAM-Coated Silica Nanoparticles for the Imaging of HER2-Expressing Cancer Cells.
Yamaguchi H; Tsuchimochi M; Hayama K; Kawase T; Tsubokawa N
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399687
[TBL] [Abstract][Full Text] [Related]
37. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
[TBL] [Abstract][Full Text] [Related]
38. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
[TBL] [Abstract][Full Text] [Related]
39. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
40. Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging.
Chen X; Zhou H; Li X; Duan N; Hu S; Liu Y; Yue Y; Song L; Zhang Y; Li D; Wang Z
EBioMedicine; 2018 Apr; 30():129-137. PubMed ID: 29574092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
